Nemeskéri et al. - 2006 - Induced acute erythema and late pigmentation may not be correlated in regards to Perera et al. (Int J Radiat Oncol Biol Phys 2005621283-1290). - Int J Radiat Oncol Biol Phys.pdf
Perera F., Chisela F., Stitt L., et al. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1283-1290
Póti Z., Nemeskéri C., Fekésházy A., et al. Partial breast irradiation with interstitial cobalt-60 brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 58 (2004) 1022-1033
Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53 (2002) 889-897
Fentiman I.S., Deshmane V., Tong D., et al. Caesium137 implant as sole radiation therapy for operable breast cancer. A phase II trial. Radiother Oncol 71 (2004) 281-285
King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 180 (2000) 299-304
Polgár C., Major T., Fodor J., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery. Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
